BioCryst Pharmaceuticals Earnings Estimate
| BCRX Stock | USD 7.60 0.11 1.47% |
BioCryst Pharmaceuticals Revenue Breakdown by Earning Segment
By analyzing BioCryst Pharmaceuticals' earnings estimates, investors can diagnose different trends across BioCryst Pharmaceuticals' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, BioCryst Pharmaceuticals' Gross Profit is fairly stable compared to the past year. Gross Profit Margin is likely to rise to 1.04 in 2024, whereas Pretax Profit Margin is likely to drop (0.72) in 2024.
BioCryst |
BioCryst Pharmaceuticals Earnings per Share Projection vs Actual
About BioCryst Pharmaceuticals Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of BioCryst Pharmaceuticals earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current BioCryst Pharmaceuticals estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as BioCryst Pharmaceuticals fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -1.7 B | -1.6 B | |
| Retained Earnings Total Equity | -1.1 B | -1 B | |
| Earnings Yield | (0.20) | (0.21) | |
| Price Earnings Ratio | (5.08) | (5.34) | |
| Price Earnings To Growth Ratio | 0.45 | 0.47 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioCryst Stock Analysis
When running BioCryst Pharmaceuticals' price analysis, check to measure BioCryst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCryst Pharmaceuticals is operating at the current time. Most of BioCryst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of BioCryst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCryst Pharmaceuticals' price. Additionally, you may evaluate how the addition of BioCryst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.